REQUEST A DEMO
Total
USD $0.00
Search more companies

Takeda Biopharmaceuticals India Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Takeda Biopharmaceuticals India Private Limited Profile Updated: August 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Takeda Biopharmaceuticals India Private Limited is an unlisted company, incorporated on 15/04/2015. It has its registered office in the State of Haryana, India. Company's corporate identification number (CIN) is U51909HR2015FTC055144 and registration number is 055144. The company is a trade company, it is engaged in wholesale trading.

Legal Address
6Th Floor, Tower C, Building No. 8, Dlf Cyber City, Dlf Phase Ii
Gurgaon; Haryana; Postal Code: 122001

Contact Details: Purchase the Takeda Biopharmaceuticals India Private Limited report to view the information.

Website: http://www.takeda.com

Basic Information
Total Employees:
Purchase the Takeda Biopharmaceuticals India Private Limited report to view the information.
Outstanding Shares:
Purchase the Takeda Biopharmaceuticals India Private Limited report to view the information.
Registered Capital:
Purchase the Takeda Biopharmaceuticals India Private Limited report to view the information.
Incorporation Date:
April 15, 2015
Key Executives
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
92.91%
Company Performance
Financial values in the chart are available after Takeda Biopharmaceuticals India Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
1.63%
Total operating revenue
0.36%
Operating profit (EBIT)
18.7%
EBITDA
21.1%
Net Profit (Loss) for the Period
39.53%
Total assets
-12.25%
Total equity
5.99%
Operating Profit Margin (ROS)
0.69%
Net Profit Margin
1%
Return on Equity (ROE)
1.2%
Quick Ratio
0.14%
Cash Ratio
-0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?